Florenzo Iannone
YOU?
Author Swipe
View article: The impact of demographics on organ damage in Behçet’s syndrome: a cross-sectional analysis of the international PROBE cohort
The impact of demographics on organ damage in Behçet’s syndrome: a cross-sectional analysis of the international PROBE cohort Open
Objective To examine the influence of demographics on organ damage in a broad, multiethnic cohort of patients with Behçet’s Syndrome (BS). Methods In this cross-sectional ancillary analysis of the PROBE project, the investigated demographi…
View article: Sjögren’s disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessment
Sjögren’s disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessment Open
Fibromyalgia (FM) is more prevalent in patients with Sjögren’s disease (SjD) than in the general population and a bidirectional association between the two conditions has been proposed. However, the clinical profile of patients with concom…
View article: The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung disease
The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung disease Open
Objective. In the absence of national and European guidelines on the treatment of rheumatoid arthritis (RA) with interstitial lung disease (ILD), the Italian Society of Rheumatology decided to develop national clinical practice guidelines …
View article: Sjögren’s disease and concomitant Fibromyalgia: clinical profile and implications for disease activity assessment
Sjögren’s disease and concomitant Fibromyalgia: clinical profile and implications for disease activity assessment Open
Objectives: Fibromyalgia (FM) is more prevalent in patients with Sjögren’s disease (SjD) than in the general population and a bidirectional association between the two conditions has been proposed. However, the clinical profile of patients…
View article: Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry Open
Objectives To investigate cutaneous manifestations in Still’s disease patients, evaluating any correlation with ethnic origin, age at disease onset, disease patterns, occurrence of macrophage activation syndrome (MAS) and systemic activity…
View article: Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry Open
Objectives To describe the prevalence of gastrointestinal (GI) symptoms in SSc and Very Early Diagnosis of SSc (VEDOSS), identify clinical and serological features associated with GI involvement and explore a cranio-caudal pattern of sympt…
View article: Development and implementation of the International AIDA Network Castleman’s disease registry
Development and implementation of the International AIDA Network Castleman’s disease registry Open
Castleman’s disease (CD) consists of a wide spectrum of rare disorders classified into unicentric CD and multicentric CD (MCD), based on the diffusion of disease distribution and the severity of clinical manifestations. While unicentric CD…
View article: Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study Open
Systemic sclerosis (SSc) is a chronic autoimmune disease with multi-organ involvement. Historically, SSc classification has focused on the type of skin involvement (limited versus diffuse); however, a growing evidence of organ-specific var…
View article: Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers
Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers Open
Objectives To evaluate whether the impairment of aquaporin-4 (AQP4), a water channel protein important for muscle function, may be associated with dysphagia in idiopathic inflammatory myopathies (IIMs). Swallowing muscle inflammation in II…
View article: Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis Open
Spondyloarthritis (SpA) encompasses a group of chronic inflammatory diseases with overlapping genetic, clinical, and radiographic features. Axial spondyloarthritis (axSpA), a subset of SpA, predominantly involves the sacroiliac joints and …
View article: Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment Open
Still's disease is an inflammatory syndrome affecting patients across all ages, previously known as systemic juvenile idiopathic arthritis (sJIA) in children and adult-onset Still's disease (AOSD) in adults. Multiple lines of evidence repo…
View article: First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry Open
Introduction Primary heart involvement (pHI) is an overlooked and poorly characterised complication of systemic sclerosis (SSc), associated with the risk of heart failure, arrhythmia and death. Despite consensus definition by the World Scl…
View article: Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study Open
This study provides insights into epidemiological, clinical, and therapeutic features of SLE across referral centers highlighting significant regional disparities and emphasizing the need to increasingly align with EULAR recommendations ev…
View article: Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) Open
Background: Hormonal changes in menopause might interact with the presentation of underlying autoimmune diseases, such as systemic sclerosis (SSc). Objectives: Our study aimed to evaluate the association of (1) current menopausal status, (…
View article: Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients Open
Background/Objectives: Psoriatic arthritis (PsA) is a chronic inflammatory condition that primarily affects the musculoskeletal system and skin. While biologic and targeted synthetic DMARDs have improved treatment, many patients still fail…
View article: Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study Open
Objectives This study assessed how changes in lung function, skin fibrosis and digital ulceration (DU) burden predict mortality in patients with SSc-associated interstitial lung disease (SSc-ILD), the leading cause of death in SSc. Methods…
View article: OP0040 Trajectory and Determinants of Organ Damage Accrual in Behçet's Syndrome: 1-Year Preliminary Results from the PROBE Study
OP0040 Trajectory and Determinants of Organ Damage Accrual in Behçet's Syndrome: 1-Year Preliminary Results from the PROBE Study Open
View article: POS0275 EVALUATION OF A LARGE LANGUAGE MODEL'S PERFORMANCE IN SCORING CUTANEOUS MANIFESTATIONS IN DERMATOMYOSITIS: A COMPARISON WITH EXPERT ASSESSORS
POS0275 EVALUATION OF A LARGE LANGUAGE MODEL'S PERFORMANCE IN SCORING CUTANEOUS MANIFESTATIONS IN DERMATOMYOSITIS: A COMPARISON WITH EXPERT ASSESSORS Open
View article: POS0975 PROFILING SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS STARTING TREATMENT WITH ANIFROLUMAB: INSIGHTS FROM THE MULTICENTER PROSPECTIVE OBSERVATIONAL REVEAL STUDY
POS0975 PROFILING SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS STARTING TREATMENT WITH ANIFROLUMAB: INSIGHTS FROM THE MULTICENTER PROSPECTIVE OBSERVATIONAL REVEAL STUDY Open
View article: ABS0781 GUSELKUMAB EFFICACY IN PSORIATIC ARTHRITIS: A REAL-WORLD EVIDENCE COMPARISON STUDY WITH ADALIMUMAB AND IL-17A INHIBITORS FROM THE MULTICENTER PROSPECTIVE BIOlogic aPUlian REgistry (BIOPURE)
ABS0781 GUSELKUMAB EFFICACY IN PSORIATIC ARTHRITIS: A REAL-WORLD EVIDENCE COMPARISON STUDY WITH ADALIMUMAB AND IL-17A INHIBITORS FROM THE MULTICENTER PROSPECTIVE BIOlogic aPUlian REgistry (BIOPURE) Open
View article: POS0265 AGE AND TIMING OF ONSET OF RAYNAUD'S PHENOMENON AND FIRST NON-RAYNAUD SIGN/SYMPTOM AS PROGNOSTIC FACTORS IN SYSTEMIC SCLEROSIS: A RETROSPECTIVE ANALYSIS FROM THE SPRING (SYSTEMIC SCLEROSIS PROGRESSION INVESTIGATION) REGISTRY OF THE ITALIAN SOCIETY FOR RHEUMATOLOGY
POS0265 AGE AND TIMING OF ONSET OF RAYNAUD'S PHENOMENON AND FIRST NON-RAYNAUD SIGN/SYMPTOM AS PROGNOSTIC FACTORS IN SYSTEMIC SCLEROSIS: A RETROSPECTIVE ANALYSIS FROM THE SPRING (SYSTEMIC SCLEROSIS PROGRESSION INVESTIGATION) REGISTRY OF THE ITALIAN SOCIETY FOR RHEUMATOLOGY Open
View article: OP0111 Digital Biomarkers in Rheumatoid Arthritis: Single-Camera Motion Capture Meets Computer Vision. External validation of the Mefisto study
OP0111 Digital Biomarkers in Rheumatoid Arthritis: Single-Camera Motion Capture Meets Computer Vision. External validation of the Mefisto study Open
View article: ABS0573 RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN
ABS0573 RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN Open
View article: POS0585 SEX DIFFERENCES IN THE SAFETY PROFILE OF JANUS KINASE INHIBITORS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE JAK-POT INTERNATIONAL COLLABORATION
POS0585 SEX DIFFERENCES IN THE SAFETY PROFILE OF JANUS KINASE INHIBITORS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE JAK-POT INTERNATIONAL COLLABORATION Open
View article: ABS1150 SEX-BASED DIFFERENCES IN PREDICTORS OF SECUKINUMAB EFFECTIVENESS IN EUROPEAN ROUTINE CARE PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE EuroSpA COLLABORATION
ABS1150 SEX-BASED DIFFERENCES IN PREDICTORS OF SECUKINUMAB EFFECTIVENESS IN EUROPEAN ROUTINE CARE PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE EuroSpA COLLABORATION Open
View article: POS0150 EVOLUTION OF JANUS KINASE INHIBITORS (JAKi) PRESCRIPTIONS SINCE 2015 IN AN INTERNATIONAL COLLABORATION OF RHEUMATOID ARTHRITIS REGISTERS (THE ‘JAK-pot' STUDY): EFFECT OF REGULATORY WARNINGS
POS0150 EVOLUTION OF JANUS KINASE INHIBITORS (JAKi) PRESCRIPTIONS SINCE 2015 IN AN INTERNATIONAL COLLABORATION OF RHEUMATOID ARTHRITIS REGISTERS (THE ‘JAK-pot' STUDY): EFFECT OF REGULATORY WARNINGS Open
View article: OP0232 CANCER INCIDENCE AMONG RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY)
OP0232 CANCER INCIDENCE AMONG RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY) Open
View article: POS1250 ASSOCIATION BETWEEN METABOLIC COMORBIDITIES AND RETENTION RATES OF FIRST-LINE b/tsDMARD TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EUROPEAN REAL-WORLD RESULTS
POS1250 ASSOCIATION BETWEEN METABOLIC COMORBIDITIES AND RETENTION RATES OF FIRST-LINE b/tsDMARD TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EUROPEAN REAL-WORLD RESULTS Open
View article: ABS0394 REAL-WORLD EFFECTIVENESS OF UPADACITINIB ACROSS DIFFERENT CLINICAL PHENOTYPES IN A LARGE ITALIAN PsA COHORT
ABS0394 REAL-WORLD EFFECTIVENESS OF UPADACITINIB ACROSS DIFFERENT CLINICAL PHENOTYPES IN A LARGE ITALIAN PsA COHORT Open
View article: POS1429 CHAPERONE-MEDIATED AUTOPHAGY IN SYNOVITIS DISTINGUISHES PSORIATIC ARTHRITIS FROM RHEUMATOID ARTHRITIS
POS1429 CHAPERONE-MEDIATED AUTOPHAGY IN SYNOVITIS DISTINGUISHES PSORIATIC ARTHRITIS FROM RHEUMATOID ARTHRITIS Open